On July 16, 2015, Mezzion Pharma Co.,Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,680 KRW | -0.13% | +5.49% | -22.42% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.42% | 235M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- A095700 Stock
- News Genexine, Inc.
- Mezzion Pharma Co.,Ltd. announced that it has received KRW 42 billion in funding from a group of investors.